Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,153
Total Claims
$273K
Drug Cost
994
Beneficiaries
$275
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
-93%
Cost per patient vs peers
$275 vs $4,034 avg
-61%
Brand preference vs peers
3.7% vs 9.4% avg
Brand vs Generic
Brand: 332 claims · $83K
Generic: 8,756 claims · $189K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivastigmine | 182 | $32K |
| Galantamine Hbr | 399 | $28K |
| Memantine Hcl | 1,338 | $22K |
| Donepezil Hcl | 1,923 | $13K |
| Rotigotine | 13 | $12K |
| Rivastigmine | 16 | $11K |
| Levetiracetam | 13 | $11K |
| Rasagiline Mesylate | 47 | $9,974 |
| Diclofenac Potassium | 194 | $9,073 |
| Carbamazepine | 59 | $8,916 |
| Gabapentin | 807 | $6,323 |
| Phenytoin Sodium Extended | 35 | $5,984 |
| Carbidopa/Levodopa | 12 | $5,976 |
| Divalproex Sodium | 12 | $5,385 |
| Carbamazepine | 12 | $5,374 |
Prescribing Profile
52
Unique Drugs
12.0
Anomaly Score
Patient Profile
74
Avg Age
59%
Female
2.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About